Global Cardiac Resynchronization Therapy Defibrillator Market 2016-2020

Overview of the cardiac resynchronization therapy defibrillator (CRT-D) market

Technavio’s market research analysts predict the global cardiac resynchronization therapy defibrillator (CRT-D) market to grow at a CAGR of more than 8% by 2020. Factors such as rising incidences of cardiac disorders, advanced surgical procedures such as minimally invasive (MI) surgeries, patient awareness, and increasing healthcare spending are the primary growth drivers for the CRT-D market. Several clinical research studies indicate that when compared to CRT-P devices, the CRT-D devices can reduce re-admissions to the hospital for patients with heart failure, which is leading to their increased implementation in several cardiac procedures. Also, CRT-D devices lower the risk of sudden cardiac death (SCD) and improve the left ventricular function.

One of the latest trends gaining prominence in the market is the development of CRT-D devices with MRI technology. The incorporation of this technology helps in better diagnosis of heart conditions and assist cardiologists in providing better treatment to patients. To minimize the manufacturing costs, several manufacturers are using such advanced technologies and materials to develop efficient devices. At present, several physicians are using 3D-MRI technique for better imaging.

Geographical segmentation and analysis of the CRT-D market

• Americas
• APAC
• EMEA

The Americas will be the largest revenue contributing region in the market by 2020 and is expected to occupy more than 55% of the total market share. The rising incidences of cardiac disorders and growing awareness about cardiac diseases are the primary growth drivers for this region. Factors such as growing number of implant centers, technological advancements and easy availability of reimbursements will propel the sales of CRT-D devices in the region.